-
Behavioral Health Barometer: Region 10, Volume 7: Indicators as Measured in the 2021-2022 National Surveys on Drug Use and Health [Internet].
Rockville (MD): Substance Abuse and Mental Health Services Administration (US); 2024 Apr.
-
Ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model.
Health Technology Assessment, No. 28.73.
Harnan S, Kearns B, Scope A, et al.
Southampton (UK): National Institute for Health and Care Research; 2024 Oct.
-
Genedrive kit for detecting single nucleotide polymorphism m.1555A>G in neonates and their mothers: a systematic review and cost-effectiveness analysis.
Health Technology Assessment, No. 28.75.
Shabaninejad H, Kenny RPW, Robinson T, et al.
Southampton (UK): National Institute for Health and Care Research; 2024 Oct.
-
Take-home naloxone in multicentre emergency settings: the TIME feasibility cluster RCT.
Health Technology Assessment, No. 28.74.
Snooks H, Benger J, Bell F, et al.
Southampton (UK): National Institute for Health and Care Research; 2024 Oct.
-
Treatment of Stages I-III Squamous Cell Anal Cancer: A Systematic Review [Internet].
Comparative Effectiveness Review, No. 273.
Parikh RR, Troester A, Southwell B, et al.
Rockville (MD): Agency for Healthcare Research and Quality (US); 2024 Aug.
See more...
Image credit: SEM Penicillium mold and spores; David Gregory and Debbie Marshall, Wellcome Images